NEW YORK, Sept. 28 - Orchid BioSciences has won a three-year, $4.8 million contract from the Office of Special Technology of the US Defense Advanced Research Projects Agency to develop technology for microfluidic-enabled DNA synthesis that can produce “significant quantities” of long oligos, the company said on Friday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.